RESUMO
How is effort integrated in value-based decision-making? Animal models and human neuroimaging studies primarily linked the anterior cingulate cortex (ACC) and ventral striatum (VS) to the integration of effort in valuation. Other studies demonstrated the role of these regions in invigoration to effort demands, thus it is hard to separate the neural activity linked to anticipation and subjective valuation from actual performance. Here, we studied the neural basis of effort valuation separated from performance. We scanned forty participants with fMRI, while they were asked to accept or reject monetary gambles that could be resolved with future performance of a familiar grip force effort challenge or a fixed risk prospect. Participants' willingness to accept prospective gambles reflected discounting of values by physical effort and risk. Choice-locked neural activation in contralateral primary sensory cortex and ventromedial prefrontal cortex (vmPFC) tracked the magnitude of prospective effort the participants faced, independent of choice time and monetary stakes. Estimates of subjective value discounted by effort were found to be tracked by the activation of a network of regions common to valuation under risk and delay, including vmPFC, VS and sensorimotor cortex. Together, our findings show separate neural mechanisms underlying prospective effort and actual effort performance.
Assuntos
Encéfalo/fisiologia , Comportamento de Escolha/fisiologia , Mapeamento Encefálico/métodos , Feminino , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Recompensa , Adulto JovemRESUMO
This paper describes data collected from a cross-sectional convenience sample of 200 healthy human volunteers between 16 and 81 years of age. We assembled an extensive battery of measures of risk preference, impulsivity, and self-control, as well as a range of demographic and cognitive measures, Crucially, we adopted different measure categories, including self-reports, informant reports, behavioral measures, and biological measures (hormones, brain function) to capture individual differences, and adopted a within-participant design. Data collection took place over multiple sessions. First, participants completed a laboratory session at the university during which we collected computer-assisted self-report measures (i.e., standardized questionnaires) as well as behavioral measures using computerized tasks. Second, participants independently completed a home session that included the completion of self-report measures, and the collection of saliva samples. In parallel, we acquired informant reports from up to three individuals nominated by the study participants. Third, participants completed a final session at the local hospital during which we collected structural and functional neuroimaging data, as well as further self-report measures. The data was collected to address questions concerning the developmental trajectories of risk preference and related constructs while assessing the impact of the assessment method; however, we invite fellow researchers to benefit from and further explore the data for research on decision-making under risk and uncertainty in general, and to apply novel analytical approaches (e.g., machine-learning applications to the neuroimaging data). Combining a large set of measures with a within-participant design affords a wealth of opportunities for further insights and a more robust evidence base supporting current theorizing on (age-related) differences in risk preference, impulsivity, and self-control.
RESUMO
RATIONALE: Serotonin (5-HT) plays a key role in different aspects of value-based decision-making. A recent framework proposed that tonic 5-HT (together with dopamine, DA) codes future average reward expectations, providing a baseline against which possible choice outcomes are compared to guide decision-making. OBJECTIVES: To test whether high 5-HT levels decrease loss aversion, risk-seeking for gains, and risk-seeking for losses. METHODS: In a first session, 611 participants were genotyped for 5-HTTLPR and performed a mixed gambles (MGA) task and two probability discounting tasks for gains and losses, respectively (PDG/PDL). Afterwards, a subsample of 105 participants (44 with S/S, 6 with S/L, 55 with L/L genotype) completed the pharmacological study using a crossover design with tryptophan depletion (ATD), loading (ATL), and balanced (BAL) conditions. The same decision constructs were assessed. RESULTS: We found increased risk-seeking for losses in S/S compared to L/L individuals at the first visit (p = 0.002). Neither tryptophan depletion nor loading affected decision-making, nor did we observe an interaction between intervention and 5-HTTLPR genotype. CONCLUSION: Our data do not support the idea that transient changes of tonic 5-HT affect value-based decision-making. We provide evidence for an association of 5-HTTLPR with risk-seeking for losses, independent of acute 5-HT levels. This indicates that the association of 5-HTTLPR and risk-seeking for losses is mediated via other mechanisms, possibly by differences in the structural development of neural circuits of the 5-HT system during early life phases.